Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms

International Journal of Radiation Oncology Biology Physics

Volumn 60, Issue 1, 2004, Pages 171-177

  Su, Catherine K ^a   Mehta, Vivek ^b   Ravikumar, Lavanya ^a   Shah, Rachit ^a   Pinto, Harlan ^a   Halpern, Jerry ^a   Koong, Albert ^a   Goffinet, Don ^a   Le, Quynh Thu ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SWEDISH MEDICAL CENTER   (United States)

Author keywords

Aloe vera; Head and neck cancer; Mucositis; Prevention; Radiotherapy

Indexed keywords

QUALITY-OF-LIFE; WEIGHT LOSS;

CARCINOGENS; CHEMOTHERAPY; DISEASES; RADIATION EFFECTS; STATISTICAL METHODS; TOXICITY; TUMORS;

RADIOTHERAPY;

ALOE VERA EXTRACT; PLACEBO;

ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; HEAD AND NECK CANCER; HUMAN; HYDRATION; INTERMETHOD COMPARISON; MOUTH INFECTION; MUCOSA INFLAMMATION; PAIN; PATIENT SATISFACTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TOXICITY; WEIGHT REDUCTION;

ALOE; DOUBLE-BLIND METHOD; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MULTIVARIATE ANALYSIS; PHYTOTHERAPY; QUALITY OF LIFE; RADIATION INJURIES; STOMATITIS;

EID: 4444339829     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.02.012     Document Type: Article

References (28)

1. Yagi A., Kabash A., Mizuno K., et al. Radical scavenging glycoprotein inhibiting cyclooxygenase-2 and thromboxane A2 synthase from aloe vera gel. Planta Med. 69:2003;269-271
2. Efron B. Forcing a sequential experiment to be balanced. Biometrika. 58:1972;403-417
3. Pocock J.J., Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 31:1975;103-117
4. Miller R.G., Efron B., Brown B.W., et al. Biostatistics casebook. 1980;John Wiley & Sons, Edison, NJ
5. Chapko M.K., Syrjala K.L., Schilter L., et al. Chemoradiation toxicity during bone marrow transplantation Time course and variation in pain and nausea. Bone Marrow Transplant. 4:1989;181-186
6. Barrantes E., Guinea M. Inhibition of collagenase and metalloproteinases by aloins and aloe gel. Life Sci. 72:2003;843-850
7. Maze G., Terpolilli R.N., Lee M. Aloe vera extract prevents aspirin-induced acute gastric mucosal injury in rats. Med Sci Res. 25:1997;765-766
8. Rees T.D. Oral ulcers remedy gets FDA clearance. J Am Dental Assoc. 125:1994;1308-1310
9. Plemons J.M., Rees T.D., Binnie W.H., et al. Evaluation of acemannan in the treatment of recurrent aphthous stomatitis. Wounds. 6:1994;40-45
10. Heggie S., Bryant G.P., Tripcony L., et al. A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nursing. 25:2002;442-451
11. Davis R., Kabbani J., Maro N. Aloe vera and wound healing. J Am Podiatr Med Assoc. 77:1987;165-169
12. Davis R., Leitner M., Russo J., et al. Wound healing Oral and topical activity of aloe vera. J Am Podiatr Med Assoc. 79:1989;559-562
13. Tizard I., Busbee D., Maxwell B., et al. Effects of acemannan, a complex carbohydrate, on wound healing in young and aged rats. Wounds. 6:1994;201-209
14. Williams M.S., Burk M., Loprinzi C.L., et al. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys. 36:1996;345-349
15. Fisher J., Scott C., Stevens R., et al. Randomized phase III study comparing best supportive care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys. 48:2000;1307-1310
16. Foote R.L., Loprinzi C.L., Frank A.R. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J Clin Oncol. 12:1994;2630-2633
17. Wijers O., Levandag P., Harms E., et al. Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck A placebo-controlled double blind randomized study. Int J Radiat Oncol Biol Phys. 50:2001;343-352
18. El-Sayed S., Nabid A., Shelley W., et al. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer A double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system. J Clin Oncol. 19:2002;3956-3963
19. Symonds R.P., McIlroy P., Khorrami J., et al. The reduction of radiation mucositis by selective decontamination antibiotic pastilles A placebo-controlled double-blind trial. Br J Cancer. 74:1996;312-317
20. Brizel D.M., Wasserman T.H., Henke M., et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 19:2000;3339-3345
21. Carter D.L., Hebert M.E., Smink K., et al. Double blind randomized trial of sucralfate vs. placebo during radical radiotherapy for head and neck cancers. Head Neck. 21:1999;760-766
22. Franzen L., Henriksson R., Littbrand B., et al. Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region A double-blind placebo-controlled study. Acta Oncol. 34:1995;219-233
23. Warde P., O'Sullivan B., Aslanidis J., et al. Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 54:2002;9-13
24. Bensaudoun R.J., Franquin J.C., Ciasis G., et al. Low-energy He/Ne laser in the prevention of radiation-induced mucositis A multicenter phase III randomized study in patients with head and neck cancer. Support Care Cancer. 7:1999;244-252
25. Cartee L., Petros W.P., Rosner G.L., et al. Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis A randomized, double blind, dose ranging study. Cytokine. 7:1995;471-477
26. Mantovani G., Massa E., Astara G., et al. Phase II trial of local use of GM-CSF for prevention and treatment of chemotherapy and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients An evaluation of effectiveness, safety and costs. Oncol Rep. 10:2003;197-206
27. Meropol N.J., Somer R.A., Gutheil J., et al. Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy Potential role as mucosal protectant. J Clin Oncol. 21:2003;1452-1458
28. Brizel D. Personal communication. June 2003